Press release Communiqué de presse

Share the news     Partagez les nouvelles

Email Facebook LinkedIn Twitter

Press release Communiqué de presse

September 4, 2001 4 September, 2001

Pamela Wallin Appointed to Pheromone Sciences Board of Directors

Pheromone Sciences Corp (CDNX:PHS), is pleased to announce the appointment of Ms. Pamela Wallin, renowned Canadian journalist, broadcaster and businesswoman, to its Board of Directors.

Ms. Wallin brings a wealth of knowledge to the Pheromone Sciences' Board of Directors given her long- standing interest in women's health issues and an outstanding media career that has spanned some twenty- five years. Television journalist and author, Ms. Wallin currently hosts Pamela Wallin's Talk TV for the CTV group. Her latest book, Speaking of Success: Collected Wisdom, Insights and Reflections is scheduled to be published in September. Ms. Wallin has garnered a long list of awards during her career including the United Nations UNIFEM Canada Award for outstanding contributions toward the advancement of women and the Saskatchewan Order of Merit, the provinces highest honour to thank those who have dedicated their lives to improving their communities.

Ms. Wallin is very active in community affairs. Amongst her activities she currently sits on the Board of Directors of the University Health Network in Toronto, the Board of Governors of the University of Waterloo and she is a patron of the Genesis Research Foundation, Advancing Women's Health. She was educated at the University of Regina receiving an honours degree in psychology and political science and has since been awarded honorary degrees from the University of Western Ontario, Ryerson Polytechnic University, Wilfrid Laurier University and Loyalist College.

"Ms. Wallin is a wonderful addition to the Board of Directors," commented Dr. William Cochrane, Chairman of Pheromone Sciences Corp. "Through a combination of media experience, entrepreneurship and public policy interest that is unmatched in Canada, Pamela will bring a broader perspective to the Company."

The appointment, which is subject to regulatory approval, is part of an ongoing program to enhance the independent nature of the Board.

Pheromone Sciences Corp. is a biotechnology and medical diagnostics device research and development company that focuses on commercializing technologies in the field of human reproduction and sexuality.

Statements contained in this press release, including those pertaining to scientific and clinical research, commercialization plans, strategic alliances, and intellectual property protection, other than statements of historical fact, are forward-looking statements subject to a number of uncertainties that could cause actual results to differ materially from statements made. The Canadian Venture Exchange has not reviewed and does not accept responsibility for the adequacy or the contents of this news release.